Search

everythinglearnresearchcommunity

for

Search:↓

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed to grow hair.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Certain growth factors regulate hair growth cycles, male hormones affect hair cycles, and drugs like Minoxidil and Finasteride can stimulate hair growth and inhibit male pattern baldness respectively.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

People with male pattern baldness are more likely to have metabolic syndrome.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Early greying and male pattern baldness can predict heart disease in young Asian men.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Hair transplantation improves life quality and self-esteem in men with male pattern baldness.

The document is about male pattern baldness.

There is no significant link between male pattern baldness and insulin resistance.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

PRP therapy is effective for treating male pattern baldness.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Low-dose oral minoxidil effectively treats male pattern baldness.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Topical minoxidil showed promise for early male pattern baldness.

Higher serum androgens contribute to male pattern baldness.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Both genetics and lifestyle factors contribute to male pattern baldness.

PRP treatment can increase hair growth in male pattern baldness, but this effect is not linked to the levels of growth factors or the number of platelets.